nView Medical

About the offering

nView medical partners with leading pediatric hospitals, offering AI-powered 3D imaging solutions designed to enhance surgical precision and workflow efficiency. The Pitch nView medical is advancing surgical imaging with AI-powered image generation technology focused on precision, efficiency and safety. The FDA-cleared nView s1 system has been used in over 500 surgeries across leading U.S. hospitals, with the goal of reducing radiation exposure and enhancing accuracy. The company is backed by $8.5M in venture capital, grant, and angel investor funding, a leadership team with decades of med-tech experience, and 8 granted patents. After a strong launch in pediatrics with over $1M in revenue, nView medical plans to expand into the $6B U.S. adult surgical market. The Problem Surgeons face a difficult trade-off: use fast 2D imaging that doesn’t give the full picture, or resort to time-consuming 3D scans that expose patients to high doses of radiation. As a result, they often revert to 2D imaging compromising on precision. We believe there are not currently any solutions that combine fast, low-radiation, and true 3D imaging in the operating room, directly impacting surgical outcomes and patient safety. Our Solution nView medical addresses this challenge with the nView s1, an AI-powered 3D imaging and navigation system that provides real-time, high-resolution and low-radiation images. With FDA clearance and used in over 500 surgeries, the nView s1 system integrates seamlessly into surgical workflows, improving accuracy and efficiency. Surgical disposables and service contracts generate recurring revenue from existing users and complement revenue from equipment placements that in turn increase the user base. The Market Following an initial launch in the $250M U.S. pediatric surgical imaging market, nView medical now plans to expand into the $6B U.S. adult surgical imaging market. Pediatric scoliosis is a foundation to expand into adult spinal deformity and minimally invasive surgeries that are increasingly performed in Ambulatory Surgical Centers (ASC). The nView s1 is being adopted in orthopedic surgery, with growing interest in the adult market. Beyond surgical imaging, we believe the technology has applications in our internally calculated total addressable market of $10B U.S. X-ray medical imaging market1, 2, 3, 4, inclusive of CT-scans and X-ray systems for diagnostic imaging. We believe nView medical technology has the potential to provide a low-cost, low-dose alternative to traditional 3D scanners in select applications and that AI-powered imaging has potential applications in point-of-care imaging for clinics, emergency medicine, first responders, and remote locations. Our Traction Backed by $8.5M in grant and investor funding, and with 8 granted patents, we have received FDA clearance for the nView s1, covering imaging, navigation and AI planning for pediatric and adult patients. The nView s1has been commercially deployed in top-tier U.S. pediatric hospitals, including Stanford Children’s, Texas Scottish Rite, and St. Louis Children’s, and used in more than 500 surgeries. We believe early adoption in pediatrics highlights its potential for addressing complex surgical accuracy and radiation safety challenges. Graph reflects internal company data on system usage from February 2022 to February 2025. past performance is not indicative of future results. This testimonial may not be representative of the experience of other customers and is not a guarantee of future performance or success. Why Invest Invest in cutting-edge AI image generation technology that aims to enhance precision and reduce radiation exposure. nView medical is an award winning company with FDA clearance for the s1 technology that has already been adopted in top-tier US hospitals and used in over 500 surgeries. Funds raised are intended to help nView medical expand into the $6B U.S. adult surgical market by helping accelerating R&D and commercialization. Join the AI-imaging revolution and be part of the transformation in surgical imaging — invest in nView today!

FAQ